ClinicalTrials.Veeva

Menu

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Benign Prostatic Hyperplasia (BPH)

Treatments

Procedure: holmium laser enucleation of the prostate

Study type

Observational

Funder types

Other

Identifiers

NCT03460873
2015-11-037

Details and patient eligibility

About

Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate

Enrollment

432 patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patient scheduled to undergo prostatectomy using holmium laser

Exclusion criteria

  • Urethral stricture, large bladder diverticulum, bladder neck contracture

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems